Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.
Hata N, Shigeyasu K, Umeda Y, Yano S, Takeda S, Yoshida K, Fuji T, Yoshida R, Yasui K, Umeda H, Takahashi T, Kondo Y, Kishimoto H, Mori Y, Teraishi F, Yamamoto H, Michiue H, Nakamura K, Tazawa H, Fujiwara T. Hata N, et al. Among authors: shigeyasu k. Sci Rep. 2023 Feb 6;13(1):2078. doi: 10.1038/s41598-023-29397-z. Sci Rep. 2023. PMID: 36747029 Free PMC article.
Spontaneous rupture of a hepatic angiomyolipoma: Report of a case.
Aoki H, Arata T, Morihiro T, Kanaya N, Takeda S, Sui K, Shigeyasu K, Katsuda K, Tanakaya K, Takeuchi H. Aoki H, et al. Among authors: shigeyasu k. Clin J Gastroenterol. 2014 Oct;7(5):429-33. doi: 10.1007/s12328-014-0517-z. Epub 2014 Aug 9. Clin J Gastroenterol. 2014. PMID: 26184024
Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M, Hinoi T, Shimomura M, Adachi T, Saito Y, Niitsu H, Kochi M, Sada H, Sotomaru Y, Ikenoue T, Shigeyasu K, Tanakaya K, Kitadai Y, Sentani K, Oue N, Yasui W, Ohdan H. Miguchi M, et al. Among authors: shigeyasu k. PLoS One. 2016 Nov 11;11(11):e0166422. doi: 10.1371/journal.pone.0166422. eCollection 2016. PLoS One. 2016. PMID: 27835699 Free PMC article.
A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study).
Kagawa S, Muraoka A, Kambara T, Nakayama H, Hamano R, Tanaka N, Noma K, Tanakaya K, Kishimoto H, Shigeyasu K, Kuroda S, Kikuchi S, Kuwada K, Nishizaki M, Shirakawa Y, Fujiwara T. Kagawa S, et al. Among authors: shigeyasu k. Cancer Chemother Pharmacol. 2018 Feb;81(2):387-392. doi: 10.1007/s00280-017-3505-4. Epub 2017 Dec 30. Cancer Chemother Pharmacol. 2018. PMID: 29290024 Clinical Trial.
55 results